CIK 0001619856
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Caribou Biosciences, Inc.
Sign in to watch- Ticker
- CRBU
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453728228
- Phone
- +1 510-982-6030
- Business address
- 2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 5,627 shares at $6.31 ($35,506)
- 4 Exercise or conversion Chief Scientific Officer acquired 21,401 shares (option exercise)
- 4 Open-market sale VP of Finance and Controller sold 10,000 shares at $10.80 ($107,958)
- 4 Exercise or conversion Chief Legal Officer acquired 27,595 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 43,248 shares at $11.22 ($485,221)
- 4 Derivatives Options or other derivatives
- 4 Grant or award VP of Finance and Controller acquired 4,848 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Scientific Officer acquired 74,420 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
- 4/A Exercise or conversion President and CEO acquired 10,000 shares (option exercise)
- 4 Exercise or conversion VP of Finance and Controller acquired 2,274 shares (option exercise)
- 4 Exercise or conversion VP of Finance and Controller acquired 2,274 shares (option exercise)
Page 4 of 7 · 125 filings